Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Charco logo — Charco is a medtech start-up working on a system for people...

Charco

Charco is a medtech start-up working on a system for people with Parkinson's to improve their quality of life.

Founded 2019 United Kingdom Cambridge, United Kingdom 73 employees Seed Total: $7.40M Biotechnology, Health Care

General Information

Company Name Charco
Founded Year 2019
Location United Kingdom Cambridge, United Kingdom
Employees 73
Industries Biotechnology, Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Charco. To contact Charco, visit charconeurotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Charco compare?

A PDF of Charco and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Charco soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Charco

Charco is a medtech start-up founded in 2019, with its headquarters in the United Kingdom. The company is dedicated to improving the quality of life for individuals suffering from Parkinson's Disease. The flagship product, CUE1, is a focused vibrotactile stimulation device designed to alleviate the stiffness and slowness experienced by over 10 million people worldwide. Pilot participants reported significant improvements in movement, expressing that they felt smoother and better coordinated when using the device. The latest milestone for Charco was a significant £7.40MSeed Round investment on 16 November 2021, backed by prominent investors including Parkwalk Advisors, Amadeus Capital Partners, Crista Galli Ventures, The University of Tokyo Edge Capital, and MINT Venture Partners. The remarkable progress and promising impact of Charco's innovative medtech solution establish it as a compelling investment opportunity in the Biotechnology and Health Care sectors.

Business keywords: Medtech, Parkinson's Disease, Non-invasive Wearable Devices, Vibrotactile Stimulation, Neurological Disorders, Quality of Life Improvement

Services & Products

Development and distribution of non-invasive medical devices and mobile health apps for Parkinson's disease treatment and symptom management

Target Customers

Patients with Parkinson's disease and healthcare professionals specializing in neurological health

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round £7.40M 5
Parkwalk Advisors Amadeus Capital Partners Crista Galli Ventures
Parkwalk Advisors, Amadeus Capital Partners +3
16 Nov 2021
Seed Round Undisclosed -
06 Oct 2021
Seed Round Undisclosed 1
Sayinthen Vivekanantham
01 Jan 2021

Charco Alternatives & Competitors

View All Alternatives
Charco vs
INBRAIN Neuroelectronics
INBRAIN Neuroelectronics Spain

High density and high resolution graphene intelligent neural systems for BCI therapeutics *FDA Break...

Series B
126 employees
AI, Biotechnology
Compare Charco vs INBRAIN Neuroelectronics
Charco vs
Apollon
Apollon Korea South

The wearable that reads your glucose

Seed
40 employees
Biotechnology, Health Care
Compare Charco vs Apollon
Charco vs
Nexstim
Nexstim Finland

We enable personalized and effective therapies and diagnostics for challenging brain diseases and di...

Post-IPO Debt
52 employees
Biotechnology, Health Care
View all alternatives

FAQ About Charco

Charco is a medtech start-up working on a system for people with Parkinson's to improve their quality of life.
Charco was founded in 2019.
Charco is headquartered in Cambridge, United Kingdom.
Charco operates in Biotechnology and Health Care. Its work centres on Medtech, Parkinson's Disease, Non-invasive Wearable Devices and Vibrotactile Stimulation. Its customers include Patients with Parkinson's disease and healthcare professionals specializing in neurological health.
Charco has approximately 73 employees.
Charco has completed 3 funding rounds, raising a total of $7.40M. The latest funding stage is Seed.
Charco offers: Development and distribution of non-invasive medical devices and mobile health apps for Parkinson's disease treatment and symptom management.
Top alternatives and competitors to Charco include INBRAIN Neuroelectronics, Apollon, Nexstim, Macrobian Biotech, Liberate Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Charco and INBRAIN Neuroelectronics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Charco, https://bouncewatch.com/company/charco-neurotech, updated 14 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes